Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2020

May 14, 2020

SELL
$20.56 - $63.12 $1.76 Million - $5.4 Million
-85,600 Reduced 63.03%
50,200 $1.44 Million
Q4 2019

Feb 13, 2020

BUY
$28.14 - $73.01 $73,164 - $189,826
2,600 Added 1.95%
135,800 $8.61 Million
Q3 2019

Nov 08, 2019

BUY
$26.26 - $34.86 $3.5 Million - $4.64 Million
133,200 New
133,200 $3.75 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.71B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.